Replies to post #110054 on Biotech Values

[jbog]

Dew,

After the Imclone blowup, I remember that Congress instructed the FDA to pay attention to Pharma press releases/speeches with regard to FDA communications and FDA was to report any deviations to the SEC.

Would that come into play in the TEVA situation?